Cosmo Pharmaceuticals N.V. (ETR: C43)

Germany flag Germany · Delayed Price · Currency is EUR
61.50
-2.50 (-3.91%)
Dec 19, 2024, 8:00 AM CET
13.89%
Market Cap 1.03B
Revenue (ttm) 185.36M
Net Income (ttm) 69.57M
Shares Out n/a
EPS (ttm) 4.32
PE Ratio 14.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date Jul 10, 2024
Volume 200
Open 61.50
Previous Close 64.00
Day's Range 61.50 - 61.50
52-Week Range 53.00 - 86.50
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 14, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 325
Stock Exchange Deutsche Börse Xetra
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.